(Reuters) – The U.S. Federal Trade Commission is launching a probe into the role played by some companies that distribute medicines to U.S. hospitals in the shortage of chemotherapies and other drugs, the Wall Street Journal reported on Wednesday.
(Reporting by Leroy Leo in Bengaluru)
